HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 2,233-2,244 of 7,264
Drug study icon
CompletedNCT04221230

Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo

What is this study about?

Researchers compared NMRA-335140 and placebo to find out how the approaches affected depression symptoms in people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Phoenix
DepressionMedication studyAges 18–65
Countries
United States
Sponsor
Neumora Therapeutics, Inc.
Drug study icon
CompletedNCT00056472

Pharmacotherapy of Psychotic Depression

Official study title

Effectiveness of Selective Serotonin Reuptake Inhibitors Combined With Antipsychotic Medication for the Treatment of Psychotic Depression

This study has finished and is no longer accepting participants.

Multiple locations, including Worcester
Depression, SchizophreniaMedication studyAges 18+
Countries
United States, Canada
Sponsor
Weill Medical College of Cornell University
Drug study icon
CompletedNCT06058039

Effects of Oral NMRA-335140 in people with Major Depressive Disorder

What is this study about?

Researchers compared NMRA-335140 and placebo to find out how the approaches affected depression symptoms in people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Cerritos
DepressionMedication studyAges 18–65
Countries
United States, France, Bulgaria, + 5 others
Sponsor
Neumora Therapeutics, Inc.
Drug study icon
CompletedNCT06058013

Effects of Oral NMRA-335140 Versus Placebo in people with Major Depressive Disorder

What is this study about?

Researchers compared NMRA-335140 and placebo to find out how the approaches affected depression symptoms in people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Encino
DepressionMedication studyAges 18–65
Countries
United States, Canada, Brazil, + 1 other
Sponsor
Neumora Therapeutics, Inc.
Drug study icon
TerminatedNCT06029439

Safety and Effectiveness of NMRA-335140-501

What is this study about?

Researchers are studying NMRA-335140, tracking side effects to assess long-term safety and tolerability in people with depression.

This study ended early.

Multiple locations, including Huntsville
DepressionMedication studyAges 18–65
Countries
United States, France, Canada, + 8 others
Sponsor
Neumora Therapeutics, Inc.
Drug study icon
CompletedNCT01725282

Safety study of Effect and Safety of Quetiapine Extended Release (XR) in depression

Official study title

Phase 2 Study of FK949E - Double-blind, Placebo-controlled, Comparative Study in Major Depressive Disorder Patients With Inadequate Response to Existing Antidepressants

This study has finished and is no longer accepting participants.

Multiple locations, including Hokkaidou
DepressionMedication studyAges 20–64
Countries
Japan
Sponsor
Astellas Pharma Inc
Drug study icon
CompletedNCT06029426

Effects of Oral NMRA-335140 Versus Placebo in people with Major Depressive Disorder

What is this study about?

Researchers compared NMRA-335140 and placebo to find out how the approaches affected depression symptoms in people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Huntsville
DepressionMedication studyAges 18–65
Countries
United States
Sponsor
Neumora Therapeutics, Inc.
Behavioral study icon
CompletedNCT02728557

Supportive and Supportive-Expressive Treatment for Depression

Official study title

The Roles of the Therapeutic Alliance in Understanding the Effects of Attachment Orientations on Outcome in Psychotherapy

This study has finished and is no longer accepting participants.

In Haifa
DepressionBehavioural studyAges 18–60
Countries
Israel
Sponsor
University of Haifa

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.